Developing an Accurate Price Model for Personalized Medicines

Randy Vogenberg, PhD, RPh

Video Categories: Pricing

Randy Vogenberg discusses the complexities of developing pricing for personalized medicine products
October 23, 2018

The Role of Tumor Mutational Burden in Lung Cancer

Drs. Goeffrey Oxnard and Lauren Ritterhouse discuss the need for validation and standardization of Tumor Mutational Burden to make it a robust biomarker, in conjunction with PD-L1, in selecting immunotherapy for their lung cancer patients.

November 24, 2014

How to Better Establish Clinical Utility for Tests in Personalized Medicine

Dr. Gary Palmer discusses the different profile of tumors and how to make findings as general as possible to better treat the patient.